A Pharmaceutical Industry Representatives' Perspective
Communicating drug safety information to patients: Current practices and future prospectives
Date
-
Month
-
Day
Year
2 digit month, 2 digit day, 4 digit year
Date
Name of the Company
Your Role/Position in the Company
The study's objective is to evaluate the current practices of communicating drug safety information to patients and healthcare professionals and explore potential areas for improvement.
How does your company currently communicate drug safety information to patients? (Select all that apply)
Patient information leaflets
Direct-to-consumer advertisements (TV, print,digital, etc.)
Pharmaceutical company websites
Mobile applications or digital platforms
Social media platforms
Healthcare professional interactions
Other
What factors influence the choice of communication channels for drug safety information in your company? (Select all that apply)
Regulatory requirements and guidelines
Collaboration with healthcare professionals and patient advocacy groups
Target patient population and demographics
Marketing and promotional strategies
Available resources and technology infrastructure
Other
How does your company ensure that drug safety information is communicated accurately and effectively to patients?
What challenges or barriers does your company face in communicating drug safety information to patients?
How does your company engage with patients to gather feedback on drug safety information and its communication?
In your opinion, what are the key elements of successful drug safety information communication to patients?
How do you envision the future of drug safety information communication to patients? Are there any emerging trends or technologies that you believe will play a significant role?
Is your company exploring or implementing any innovative approaches or strategies to improve the communication of drug safety information to patients? If yes, please provide examples.
Thank You!
Print Form
Save
Submit Survey
Type a question
Should be Empty: